No ASX ETF holds Starpharma (SPL) as of 15 Oct 2026. Over the last year it rose 163.2%: on $10,000, +$16316. We explain 20 big moves in that time.
About SPL
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$398.2m
- Held by0 ETFs
- Big moves20 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- −8.6%peak −10.3%1 Oct 2026· Management
A board chair and deputy chair appointment announcement appears to have unsettled investors, driving an outsized sell-off beyond what sector weakness alone can explain.
- +4.3%peak +5.8%13 Aug 2026· Stake Change
Multiple directors purchased shares through the recently completed $32 million entitlement offer, signalling strong insider confidence and prompting a positive market re-rating of the stock.
- −5.4%12 Aug 2026· Capital Raise
Starpharma launched a $32 million capital raise, causing dilution and a sharp drop in the stock price.
- −7.5%peak −19.9%11 Aug 2026· Capital Raise
Starpharma's stock fell sharply after completing a $32 million renounceable entitlement offer, with new shares being quoted, causing dilution-driven selling pressure.
- +6.7%peak +8.0%5 Aug 2026· Unknown
SPL.AX rose sharply alongside a broader lift in the ASX healthcare sector, likely driven by a general sector rotation or positive sentiment across health stocks rather than any company-specific news.
- +8.0%28 Jul 2026· Sector Flow
SPL.AX rose strongly alongside a broad rally in Australian healthcare sector stocks, lifting the stock on sector-wide buying momentum.
- +8.2%19 May 2026· Sector Flow
No clear single cause identified; move appears tied to general ASX growth/sector interest around the date.
- −11.3%19 May 2026· Unknown
No direct news explains the 11.29% drop; likely reflects market sentiment from a generic analyst/sector commentary, but evidence is insufficient.
- −10.2%15 May 2026· Unknown
No specific event identified; the price decline appears to be a continuation of negative sentiment from a previous day's fall, likely tied to a general market or sector move.
- −6.0%29 Apr 2026· Unknown
No direct company-specific news explains the drop; likely broad sector or market flow given the generic nature of surrounding articles.
- +9.8%16 Apr 2026· Sector Flow
No specific company announcement found; the stock's rally appears to be part of a broader uptrend and technical breakout, as highlighted by multiple market analysis articles.
- +15.0%15 Apr 2026· Sector Flow
A significant bullish move in Starpharma's stock on April 15, 2026, without direct news coverage, likely due to a sector-wide rally in ASX 200 healthcare stocks.
- +13.4%16 Mar 2026· Unknown
Insufficient news evidence to explain the abnormal price move.
- −7.5%4 Mar 2026· Unknown
No relevant news explains the price drop; likely due to broader market or unidentified factors.
- +18.1%11 Feb 2026· Stake Change
A substantial shareholding change announcement on the event date likely triggered investor interest, possibly indicating insider or activist accumulation.
- +13.5%3 Feb 2026· Unknown
Insufficient evidence to attribute the price move to a specific driver.
- +16.2%29 Jan 2026· Sector Flow
No direct news explains the move; likely driven by sector-wide gold exploration excitement following peer drilling results.
- +15.6%12 Nov 2025· Unknown
No specific cause identified; available news articles are unrelated to Starpharma Holdings.
- +13.2%11 Nov 2025· Unknown
Insufficient direct evidence; the price move may be influenced by sector news such as Nimy Resources' gallium resource update, but no direct link to Starpharma found.
- +9.0%29 Oct 2025· Unknown
Insufficient news evidence to determine the cause of the price move.
Held by 0 ETFs
No ETF we track holds SPL directly.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs